Related Experiment Videos
Radiation myositis: the possible role of gemcitabine
G Ganem1, P Solal-Celigny, A Joffroy
1Radiation Oncology Department, Centre Jean Bernard, Le Mans, France. coutard@cybercable.tm.fr
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The European Rare Disease Network for HHT Frameworks for management of hereditary haemorrhagic telangiectasia in general and speciality care.
European journal of medical genetics·2021
[How a self-managed team can improve cohesion and communication during the patient's journey in a radiotherapy department: Experience of centre Jean-Bernard (Le Mans, France)].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2020
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
A large French multicenter retrospective series of T1-T2N0 vocal cords carcinomas treated with exclusive irradiation.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2017
Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Safety and antitumor activity of the first-in-class EGFR-HER3 bispecific antibody-drug conjugate iza-bren (BL-B01D1) in patients with pretreated locally advanced or metastatic breast cancer: a phase 1b study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Adjuvant pembrolizumab for the treatment of clear cell renal cell carcinoma: Five-year results from the phase III KEYNOTE-564 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Thymic Radiation is Associated with Worse Outcomes in Patients with NSCLC.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Five-Year Outcomes of Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer From the Randomized KEYNOTE-671 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atezolizumab with or without tiragolumab in unresectable esophageal squamous cell carcinoma following definitive concurrent chemoradiotherapy (SKYSCRAPER-07): a randomised, phase III study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Evolving person-focused cancer care: the multifaceted benefits of electronic PRO integration and radiation therapist-led follow-up in radiotherapy.
Technical innovations & patient support in radiation oncology·2026
Radiotherapy for postoperative groin lymphatic fistulas: A systematic review of clinical outcomes and treatment planning.
Clinical and translational radiation oncology·2026
Re-evaluating the α/β ratio in 2026: A systematic review and quantitative reappraisal in the era of molecular radiobiology.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists·2026
Clinical and Treatment Factors associated with Lymphopenia after Palliative Radiation Therapy in Cancer Patients.
International journal of radiation oncology, biology, physics·2026
Bayesian personalized dose constraints in selecting patients with non-small cell lung cancer for cardiac risk-adaptive treatment.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026